Elevance Health (ELV) has recently made notable changes in shareholder positioning, both in buying and selling domains. Notably, Rep. Lisa C. McClain and Gilbert Ray Cisneros have bought into the bio-tech giant, while companies such as Acadian Asset Management, Pacific Capital Partners, and IFM Investors Pty Ltd have bolstered their stakes, showing aggressive
investment activity. Other big names including Czech National Bank, Exchange Traded Concepts LLC, Sumitomo Mitsui DS Asset Management Company Ltd are also adding to their portfolios. On the other side, diverse stakeholders such as Empowered Funds LLC, Intech Investment Management, Signature Estate and Amundi have reduced their investments or sold off their holdings in ELV. Per news,
Elevance Health has had to reassess its valuation and revisit its strategic direction in the light of changing market pressures and a shift in its Medicare business. Despite a few setbacks, ELV has maintained its earnings forecast for 2025. Decisive factors for potential investment include its push into digital care and AI, growing membership numbers, its fundamentally strong market position, and continuing interest from high-profile investors.
Elevance Health ELV News Analytics from Sun, 15 Jun 2025 07:00:00 GMT to Sat, 20 Sep 2025 23:51:54 GMT -
Rating -1
- Information 6
- Rumor 4
